Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis
Purpose: Cancer is a leading cause of morbidity and mortality worldwide. Off-label (OL) use of antineoplastic drugs to treat malignancies is prevalent. In this study, we quantified and characterized OL use of antineoplastic drugs to treat malignancies in China.Methods: This was a retrospective study...
Saved in:
Main Authors: | Guoxu Wei (Author), Min Wu (Author), He Zhu (Author), Sheng Han (Author), Jing Chen (Author), Chenchen Zhai (Author), Luwen Shi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of house price growth on mental health: Evidence from China
by: Guoxu Wei, et al.
Published: (2021) -
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
by: Weilan Wang, et al.
Published: (2013) -
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China.
by: Weilan Wang, et al.
Published: (2013) -
The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting
by: Marta Herrero Fernandez, et al.
Published: (2019) -
Assesment of Adulterated Traditional Chinese Medicines in China: 2003-2017
by: Mingzhe Xu, et al.
Published: (2019)